SWOG clinical trial number
SWOG-7808

Combined Modality Treatment for Stages III and IV Hodgkin's Disease.

Closed
Phase
Published
Abbreviated Title
Combined Modality Treatment for Stages III and IV Hodgkin's Disease.
Activated
06/01/1978
Closed
12/01/1987

Research committees

Lymphoma

Publication Information Expand/Collapse

2008

The Southwest Oncology Group: progress in cancer research [PMID18929152]

CA Coltman Seminars in Oncology 35(5):545-552

1998

Treatment of grey zone lymphomas

RI Fisher Annals of Oncology 9(5):S121-S123

1996

Report of workshop 5: Early high-dose chemotherapy.

RI Fisher Annals of Oncology 7(Suppl.4):S131-S133

1994

Low-dose involved field radiation after chemotherapy in advanced Hodgkin disease: A Southwest Oncology Group study

CJ Fabian;CM Mansfield;S Dahlberg;SE Jones;TP Miller;E Van Slyck;PN Grozea;FS Morrison;CA Coltman, Jr;RI Fisher Annals of Internal Medicine 120(11):903-912

1992

Radiation consolidation following MOP-BAP for stages III & IV Hodgkin's disease: A randomized Southwest Oncology Group study

CM Mansfield;C Fabian;S Dahlberg;SE Jones;TP Miller;E van Slyck;PN Grozea;FS Morrison;CA Coltman Jr;RI Fisher Intl Journal of Radiation Oncology Biology and Physics 21(Suppl.1):191(#142)

Role of additional radiotherapy in advanced stages of Hodgkin's disease.

JH Meerwaldt;CN Coleman;RI Fisher;TA Lister;V Diehl Annals of Oncology 3(Suppl.4):S83-S85

1991

Radiation consolidation following MOP-BAP for stages III & IV Hodgkin's disease. A randomized Southwest Oncology Group study.

CM Mansfield;C Fabian;S Dahlberg;S Jones;TP Miller;EJ Van Slyck;P Grozea;F Morrison;C Coltman, Jr;RI Fisher ASTRO 2:191(#142)

1990

Comparison of lymphangiography and CT scanning in evaluating abdominal disease in stages III and IV Hodgkin's disease: A Southwest Oncology Group study.

CM Mansfield;C Fabian;S Jones;EJ Van Slyck;P Grozea;F Morrison;TP Miller;C Seibert;K Ayyangar Cancer 66(11):2295-2299

1989

Efficacy of low dose involved field (LDIF) XRT in producing and maintaining CR following PR induction with MOP-BAP chemotherapy in hodgkin's disease, results of Southwest Oncology Group study 7808

C Fabian;S Dahlberg;T Miller;S Jones;P Grozea;F Morrison;C Mansfield ASCO 8:253(#987)

1984

Response rates as a function of age in Hodgkin's disease: A SWOG study

C Fabian;R Sayre;D Dixon;C Mansfield ASCO #C-940

Lack of correlation of Ann Arbor clinical parameters and biopsy determination of liver involvement in stage III and IV Hodgkin's disease: A Southwest Oncology Group (SWOG) study

C Fabian;A Denny;C Mansfield;D Dixon 2nd International Conference on Malignant Lymphoma (Lugano June 13-16)

1983

Correlation of clinical and biopsy determination of liver involvement in Stage III and IV Hodgkin's disease: A Southwest Oncology Group (SWOG) study

C Fabian;G Bascom;C Mansfield ASCO #C-843

1982

Chemotherapy and involved field radiotherapy for Stage III-IV Hodgkin's disease

C Mansfield Radiologic Soc of North Am

1981

A protocol for combined modality treatment for Stage III and IV Hodgkin's disease: A Southwest Oncology Group study

CJ Fabian;NI Abdou;C Mansfield;A LoBuglio In: Immunopharmacologic Effects of Radiation Therapy 487-498

Other Clinical Trials

SWOG Clinical Trial Number
S2308

Randomized Phase III Study of Mosunetuzumab vs. Rituximab for Low Tumor Burden Follicular Lymphoma

Research Committee(s)
Lymphoma
Activated
08/01/2024
Accrual
1%
Open
Phase
SWOG Clinical Trial Number
CTSU/AHOD2131